Novel approaches for molecular targeted therapy against hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel approaches for molecular targeted therapy against hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 48, Issue 8, Pages 597-607
Publisher
Wiley
Online
2018-04-25
DOI
10.1111/hepr.13181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Chemotherapy for hepatocellular carcinoma: current status and future perspectives
- (2017) Masafumi Ikeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses
- (2017) Toshiyuki Tamai et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors
- (2017) Mayuko Furuta et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation
- (2016) Tetsuya Ikemoto et al. HEPATOLOGY RESEARCH
- Short-term and long-term outcomes of laparoscopic hepatectomy, microwave ablation, and open hepatectomy for small hepatocellular carcinoma: a 5-year experience in a single center
- (2016) Wenda Li et al. HEPATOLOGY RESEARCH
- TERTpromoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma
- (2016) Soo Ki Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
- (2016) Sadahisa Ogasawara et al. INVESTIGATIONAL NEW DRUGS
- Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study
- (2016) Shuichi Kaneko et al. JOURNAL OF GASTROENTEROLOGY
- Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
- (2016) Masatoshi Kudo et al. JOURNAL OF GASTROENTEROLOGY
- Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
- (2016) Kenji Ikeda et al. JOURNAL OF GASTROENTEROLOGY
- Genetic profiling of hepatocellular carcinoma using next-generation sequencing
- (2016) Kornelius Schulze et al. JOURNAL OF HEPATOLOGY
- Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment
- (2016) Masaki Kaibori et al. Oncotarget
- Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma
- (2016) Liver Cancer
- Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications
- (2015) K. Sartorius et al. Cancer Epidemiology
- FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine-Refractory Differentiated Thyroid Cancer
- (2015) A. Nair et al. CLINICAL CANCER RESEARCH
- Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
- (2015) M. Ikeda et al. CLINICAL CANCER RESEARCH
- Sorafenib treatment in Child–Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors
- (2015) Sadahisa Ogasawara et al. INVESTIGATIONAL NEW DRUGS
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
- (2015) Akihiro Fujimoto et al. Nature Communications
- Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma
- (2015) Teiji Kuzuya et al. PLoS One
- Hypertension Due to Antiangiogenic Cancer Therapy With Vascular Endothelial Growth Factor Inhibitors: Understanding and Managing a New Syndrome
- (2014) Heather Yvonne Small et al. CANADIAN JOURNAL OF CARDIOLOGY
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
- (2014) HYPERTENSION RESEARCH
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- Exploration of liver cancer genomes
- (2014) Tatsuhiro Shibata et al. Nature Reviews Gastroenterology & Hepatology
- Signal transduction in podocytes—spotlight on receptor tyrosine kinases
- (2014) Jochen Reiser et al. Nature Reviews Nephrology
- CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects
- (2014) Jin-Young Choi et al. RADIOLOGY
- Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: From Pathophysiology to Prevention and Treatment Based on Long-Acting Nitric Oxide Donors
- (2013) P. Kruzliak et al. AMERICAN JOURNAL OF HYPERTENSION
- Leptin Receptor Somatic Mutations Are Frequent in HCV-Infected Cirrhotic Liver and Associated With Hepatocellular Carcinoma
- (2013) Atsuyuki Ikeda et al. GASTROENTEROLOGY
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
- (2013) Michael A. Weber et al. JOURNAL OF HYPERTENSION
- Gastrointestinal stromal tumour
- (2013) Heikki Joensuu et al. LANCET
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment
- (2013) Hala Ahmadieh et al. Biomed Research International
- Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents
- (2012) P. Larochelle et al. Current Oncology
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
- (2012) Tokuzo Arao et al. HEPATOLOGY
- Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
- (2012) Nicola Personeni et al. JOURNAL OF HEPATOLOGY
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
- (2012) Kai Feng et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Inappropriate Elevation of Serum Thyrotropin Levels in Patients Treated with Axitinib
- (2012) Kenji Ohba et al. THYROID
- Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction
- (2011) Daiei Takahashi et al. Clinical and Experimental Nephrology
- Hepatocellular Carcinoma: Molecular and Genomic Guideline for the Clinician
- (2011) Catherine Frenette et al. Clinics in Liver Disease
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Molecular classification of hepatocellular carcinoma anno 2011
- (2011) H. van Malenstein et al. EUROPEAN JOURNAL OF CANCER
- Effect of vitamin K2 on the recurrence of hepatocellular carcinoma
- (2011) Haruhiko Yoshida et al. HEPATOLOGY
- Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies
- (2011) Jens U. Marquardt et al. JOURNAL OF HEPATOLOGY
- High-resolution characterization of a hepatocellular carcinoma genome
- (2011) Yasushi Totoki et al. NATURE GENETICS
- Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation
- (2011) Ricardo Gehrau et al. Expert Review of Gastroenterology & Hepatology
- Receptor Tyrosine Kinase Coactivation Networks in Cancer
- (2010) A. M. Xu et al. CANCER RESEARCH
- Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
- (2010) Vanessa Almendro et al. CURRENT DRUG TARGETS
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
- (2010) Theo D. Kim et al. THYROID
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib
- (2008) G. Bollee et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
- (2007) I. Tamaskar et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now